Biohaven Stock Down Fund's Turnaround Bet Sparks Hope
A patient biotech story gets a glimmer of hope as One Fund reveals a new $6 million stake in Biohaven. Here’s what th...
This guide introduces Zero Based Budgeting For Financial Success, explaining how to assign every dollar and align spending with your financial goals.
22,155 articlesA patient biotech story gets a glimmer of hope as One Fund reveals a new $6 million stake in Biohaven. Here’s what th...
As ad-tech rotates from pandemic-driven momentum to more measured growth, The Trade Desk faces a pivotal moment. This...
As GLP-1 obesity therapies surge, one company is capturing the lion’s share of prescriptions and profits. This in-dep...
A global four-week contest stitches together AI personas, crypto rewards, and influencer intrigue. Here’s how fake in...
The weight loss therapy wave has fireworks at the giants, but smart investors look for underrated weight loss stocks ...
A New York-based issuer sells rated notes backed by a pool of bitcoin-backed consumer loans, signaling a milestone fo...
Gen Z interns at a major U.S. firm show a bold trade-off: sacrifice salary to log off at 5 PM, yet still pursue C-sui...
Gen Z workers are increasingly urged to embrace friction in daily work to stay competitive as AI automates routine ta...
Small, nearly unknown biotech stocks can surge when their pipeline milestones hit. This guide breaks down how to spot...
Gusto, the San Francisco-based HR software maker, posts more than $1 billion in trailing revenue for the last 12 mont...
Pfizer is quietly building a GLP-1 obesity pipeline that could alter the competitive landscape, while investors seek ...
Palantir is navigating a mix of headwinds and catalysts as 2026 unfolds. Here are three grounded predictions palantir...